Background/Aims: Colon cancer, also known as colorectal cancer (CRC), is one of the most common malignant tumors globally. Although significant advances have been made for developing novel therapeutics, the mechanisms of progression of colorectal cancer are still poorly understood. Methods: In this study, we identified down-regulation of microRNA-214 (miR-214) as the contributing factor for CRC. Mitochondrial transcription factor A (TFAM) and miR-214 expression in tumor samples from colorectal cancer patients and cancer cell lines were examined by reverse transcription and real-Time PCR (qPCR) or Western Blotting. Results: Our data demonstrated that miR-214 was significantly down-regulated in the tissue samples from CRC patients as well as CRC derived cell lines. TFAM overexpression was also observed in CRC patients and identified as a target for miR-214. Knockdown of TFAM by miR-214 mimics significantly inhibited the proliferation of CRC cell lines. Also, down-regulation of TFAM inhibited nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) nuclear translocation and the expression of NF-κB depended genes. Conclusion: In conclusion, our data suggested that down-regulation of MiR-214 contributed to the enhanced TFAM expression and decreased proliferation of CRC cells.
Introduction
Colon cancer, also known as CRC, which originated from epithelial cells of colon or rectum, is one of the most common malignant tumors world wide [1] [2] [3] . The abnormal growth of cancer cells results in invading or spreading of cancer cells to other parts of the body. The exact causes of colon cancer are still illusive since more than 75% of colon cancer patients carry little or no genetic risk [4] . Although significant advances have been made for developing novel therapeutics, colon cancer remains an incurable disease mainly due to the multidrug resistance (MDR) for chemotherapy agents [5] . With surgical resection and aggressive chemotherapy, 50% of colorectal carcinoma patients still develop recurrent disease [1] . Tumor progression and tumor cell metastasis are a multi-step process involving in different mechanisms such as accelerated proliferation of cancer cells, the interaction between cancer cells and the extracellular matrix (ECM). Therefore, further understanding of the molecular mechanism in colon cancer is needed for developing new therapeutic approaches to improve the current chemotherapeutic regimen.
MicroRNAs (miRNAs) are a class of non-coding short RNA molecules which negatively regulate gene expression at the post-transcription level via binding with 3' untranslated region (3'UTR) of mRNAs [6] . Since the targets of a single miRNA may be multiple, abnormal expression of miRNAs during the development of cancer as well as the disease progression have been reported [7] . miRNAs have been identified as a novel post-transcription mechanism for regulating gene expression [6] and reported to play important roles in regulation of cell proliferation, migration, and differentiation [6] . Current studies identified that several miRNAs such as let-7 [8] , miR-143 and miR-126 [9, 10] which were involved in colon cancer. Furthermore, miRNAs circulating in blood were proposed as the potential biological markers for colon cancer diagnosis [11] , implying indispensable roles of miRNA in the prognosis of colon cancer.
TFAM, a high-mobility group (HMG) protein, plays a central role in mitochondrial DNA (mtDNA) replication, transcription and inheritance. TFAM is reported to be associated with tumorigenesis in breast, cervical, prostate, small cell lung cancers [12] [13] [14] [15] [16] . Also, frequent frameshift mutations in the coding mononucleotide repeat of TFAM was demonstrated in sporadic CRC derived cell lines and CRC tissues [17, 18] . Previous study suggested that the reduced mtDNA copy number increased the sensitivity of tumor cells to chemotherapeutic drugs, suggesting that TFAM could be a potential contributor for tumor progression [19] . However, little is known in regarding the posttranscriptional regulation of endogenous TFAM in CRC.
The relationship between miR-214 and TFAM was previously reported. miR-214 was considered to act as a tumor suppressor and its overexpression significantly suppressed the proliferation and migration of cervical cancer Hela and Caski cells by targeting TFAM [15, 20] . In this study, we identified the miR-214 as a novel regulator for CRC. Furthermore, downregulation of miR-214 was observed in the tumor samples obtained from CRC patients and CRC cells. Further analysis confirmed that miR-214 inhibited proliferation in CRC cells via the up-regulation of TFAM.
Materials and Methods

Ethics statement, patients and samples
Tissue samples of CRC patients who underwent resection of their tumors at the Gastrointestinal Surgery Center, the first affiliated hospital of Sun Yat-Sen University, were prospectively obtained for this study by following institutional review board guidelines. This study was reviewed and approved by the Reporter plasmid and luciferase based miRNA function assay Human TFAM 3'UTR and mutated TFAM 3'UTR were artificially synthesized by Genescript (Nanjing, China) and cloned to the reporter plasmid psiCHECK2 (Promega, Madison, WI, USA). Luciferase activities in the different cell lines transfected with psiCHECK2-PTEN-3'UTR along with miR-214 mimic or scramble control were measured by Dual-Glo® Luciferase Assay System (Promega Corp., Madison, WI, USA) following the instruction of manufacturer. The luminescence signal of luciferase was measured by a VICTORX5™ Multilabel Counter (Perkin-Elmer, Waltham, MA, USA). Relative percentages of luciferase activity were calculated by comparing with a scramble control transfected cells. qPCR TRziol Reagent (Invitrogen, Carlsbad, CA, USA) was used for total RNAs isolation from in vitro cultured CRC cells as well as tissue samples obtained from CRC patients. The cDNA generation for quantification of miRNAs expression was conducted by using Hairpin-it™ miRNA RT-PCR Quantitation kit (GenePharma, Shanghai, China) and MystiCq® microRNA qPCR Assay Primer (Sigma-Aldrich, St. Louis, MO, USA) according to manufacturer's instruction. For the evaluation of the cellular gene level, the cDNAs of in vitro cultured cells or tissue samples were obtained via reverse transcription by AMV reverse transcriptase (Promega Corp., Madison, WI, USA). A combination of oligo dT and random hexamer was used for cDNA synthesis. The qPCR detection with SYBR Green Mix (Life technologies Crop., Carlsbad, CA) for measuring the indicated genes and miR-214 expression was described previously [21, 22] . The transcript level of human RPL32 and U6 were also monitored from the same sample to serve as reference genes for normalization. The relative gene expression was quantified by the 2 -∆∆CT method as previously described [23] . Primers used in this study were listed as Table 1 .
Flow cytometry based cell cycle assay
A total of 1 × 10 6 CRC cells in each group were fixed with 70% ethanol and permeabilized by phosphate buffered saline (PBS) containing 0.5% TritonX100 along with the treatment with DNase-free RNase A (Sigma-Aldrich, St. Louis, MO, USA). Then the fixed cells were stained by propidium iodide for cell cycle analysis by flow cytometry machine (FACS Calibur, BD Bioscience, San Jose, CA, USA).
Western Blotting
Western Blotting was conducted as previously described [24] . Briefly, after denatured proteins were transferred into polyvinylidene difluoride (PVDF) membrane, the membrane was blocked and probed by rabbit anti-TFAM antibody (dilution 1:3000, Santa Cruz Biotechnology, Santa Cruz, CA, USA), or rabbit anti-NF-κB p65 (dilution 1:3000, Santa Cruz Biotechnology, Santa Cruz, CA, USA) for overnight at 4°C. Specific reactions between different antibodies and their corresponding targets were detected by using goat antirabbit conjugated with horseradish peroxidase (dilution 1:5000, Sigma, St. Louis, MO, USA) and revealed by a chemiluminescence substrate (Thermo Fisher Scientific, Waltham, Massachusetts, USA). The membrane was also probed with anti-Tubulin antibody (dilution 1:3000, Santa Cruz Biotechnology, Santa Cruz, CA, 
COX2-R CCGGGTACAATCGCACTTAT
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Clonogenic cell survival assay
Clonogenic cell survival assay was conducted as previously described with modifications as well [25] . Briefly, miR-214 mimic, miR-214 inhibitor or scramble control transfected cells were trypsinized and counted for viable cells. Totally 1×10 4 cells were seeded into 100 mm cell culture dishes and maintained for one week. Then the cell colonies were stained with gentian violet for pictures.
Statistical analysis
The statistical analysis was conducted and analyzed using One-way analysis of variance (ANOVA) in statistics package for social science (SPSS, Version 16.0, Inc., Chicago, IL, USA). Differences in indicators between treatment samples, such as luciferase activity, miR-214, TFAM mRNA and other gene levels were assessed by Student t-test. A two tailed P-value of less than 0.05 was considered significant.
Results
The miR-214 expression level was reduced in CRC patients and CRC cell lines
As demonstrated in Fig. 1A , compared with the adjuvant healthy tissues, the expression of miR-214 was significantly reduced in paired CRC tissues, suggesting a down-regulation of miR-214 in CRC (P<0.05). To further prove our findings, miR-214 expression was also examined in several CRC cell lines. The CCD18Co cell, a cell line derived from colon tissue biopsy but not cancer tissue origin was used as the normal control. Based on our data, all CRC cell lines including DIFI, HCT-116, HT-29, SW620, Caco-2, CW-2 and RKO demonstrated a reduced expression of miR-214 compared with CCD-18Co cells (P<0.05) (Fig. 1B) . Taken together, these data suggested a linkage of miR-214 downregulation and CRC.
Identification of TFAM as a putative target of miR-214
To verify if TFAM could be a putative target, the 3'UTR of TFAM mRNA contained the putative binding sequence of miR-214 was constructed. Moreover, a mutated 3'UTR with two nucleotides replacement was constructed as well ( Fig. 2A) . Since HCT-116 and SW620 cells demonstrated the lowest expression level of miR-214, both UTRs were cloned to reporter vector and transfected to these two cell lines along with miR-214 mimic or miR-214 inhibitor. The data suggested that, in the mutated 3'UTR transfected cells, no significant changes of luciferase activity was observed when reporter was co-transfected with miR-214 mimic or miR-214 inhibitor. However, there On the other hand, to further confirm these findings using the reporter assay, endogenous TFAM expression was examined at both RNA and protein levels. It was found that, compared with HCT-116 and SW620 cells transfected with scramble control, miR-214 inhibitor, TFAM mRNA expression was significantly upregulated by miR-214 mimic and reduced by miR-214 inhibitor respectively (Fig.  3A) . Additionally, the results of TFAM protein level examined by western blot were consistent with the mRNA level detected by qPCR in each group. Taken together, above data suggested that TFAM was a putative target of miR-214 in CRC cells.
Overexpression of miR-214 inhibited CRC cell proliferation
The proliferation of CRC cells treated with miR-214 mimic or scramble control was monitored by MTT assay. Compared with the HCT-116 and SW620 transfected with scramble control, the miR-214 mimic transfection significantly inhibited the proliferation CRC cell lines HCT-116 and SW620 (Fig. 4A) . To further confirm above findings, clonogenic cell survival assay was conducted as an alternative way to evaluate the capability of cell proliferation. A very strong inhibition of colonies formed by HCT-116 and SW620 was observed following miR-214 transfection (Fig. 4B and C) . Additionally, as demonstrated in Fig. 4D , miR-214 overexpression decreased the percentage of HTC-116 cells (71.36%) and SW620 cells (69.92%) in the G1/G0 phase in comparison with scramble control transfected HTC-116 cells (60.32%) and SW620 cells (62.46%). The reduced cell percentage in G1/G0 phase could be the reason why cell proliferation was reduced in miR-214 transfected CRC cells. 
Overexpression of miR-214 resulted in the reduced NF-κB nuclear translocation and the inhibited NF-κB dependent gene expression
Also, the activation of NF-κB was monitored by reporter assay. After the transfection of both NF-κB reporter plasmids and control plasmids, miR-214 mimic or miR-214 inhibitor was transfected to CRC cells as well. As shown in Fig. 5A , inhibition of TFAM via miR-214 significantly reduced luciferase activity in both HCT-116 cells and SW-620 cells. On the other hand, transfection of miR-214 inhibitor could result in the enhanced NF-κB activity (Fig. 5A ). In addition, to further verify the observations, nuclear translocation of NF-κB was also examined. It was suggested that compared with the scramble control, miR-214 overexpression reduced nuclear translocation of NF-κB p65 subunit as expected while miR-214 inhibitor exerted the reversed effects (Fig. 5B) . The expression level of the pro-apoptotic genes was examined after transfecting with miR-214 mimic and miR-214 inhibitor. As demonstrated in Fig. 5C , expression of NF-κB dependent genes such as myelocytomatosis oncogene (MYC), CyclinD1, B-cell lymphoma-extra large (Bcl-xL) and X-linked inhibitor of apoptosis (XIAP) were significantly reduced in miR-214 overexpressed HCT-116 cells and SW620 cells. Taken together, these data suggested that overexpression of miR-214 could prevent nuclear translocation of NF-κB as well as expression of NF-κB dependent genes, which might be a reason for cell proliferation inhibition by miR-214.
Down-regulation of TFAM induced by miR-214 was correlated with the reduced NF-κB nuclear translocation in CRC patients
To confirm the correlation between TFAM down-regulation induced by miR-214 and the reduced NF-κB nuclear translocation in CRC cell lines, an investigation in tissue samples from CRC patients was also conducted. The data showed that all tissue samples obtained from CRC patients demonstrated higher TFAM expression and NF-κB nuclear translocation compared with normal tissue samples (Fig. 6A) . miR-214 expression in CRC samples was downregulated with the increase of TFAM expression and NF-κB translocation (Fig. 6B) . A correlation analysis was also conducted and demonstrated in Fig.  6C which suggested a high correlation between miR-214 expression and TFAM expression and NF-κB nuclear translocation. Taken together, it was demonstrated that down-regulation of miR-214 in CRC was correlated with the evaluated TFAM level, indicating that miR-214 might be a potential marker for CRC prognosis or diagnosis.
Discussion miR-214 was reported to act as a melano-miRNA which was involved in promoting the melanoma metastasis [26] . miR-214 expression was significantly increased in oral cancer 
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Cellular Physiology and Biochemistry and pancreatic cancer and its down-regulation resulted in the inhibition of cell apoptosis [27, 28] . However, recent report suggested that miR-214 was down-regulated in cervical tumor tissues and cancer cells, and up-regulation of miR-214 leaded to the inhibition of cell growth, migration and invasion of cervical cancer cells and prompted the sensitivity to cisplatin [29, 30] . For CRC, the role of miR-214 is still unknown. There, we conducted a screen of the miR-214 level in CRC tissue samples as well as CRC cells. Our study suggested that miR-214 expression was reduced in both tissue samples from CRC patients and CRC derived cell lines. Furthermore, this study discovered that miR-214 overexpression suppressed the proliferation of CRC cells. Numerous studies have provided the evidence that miR-214 could changed biological functions of different cancer cells by its targets such as fibroblast growth factor receptor 1 (FGFR1), forkhead box M1 (FOXM1), Ras association domain family member 5 (RASSF5), Plexin-B1, phosphatase and tensin homolog (PTEN), and Ring finger and WD domain 2 (RFWD2) [27] [28] [29] [30] [31] [32] [33] [34] [35] . TFAM is a molecule which is essential for mtDNA replication and transcription, as well as mtDNA maintenance [36, 37] . The TFAM-to-mtDNA ratio is critical for both mtDNA biogenesis and homeostasis, and even small variations in the TFAMto-mtDNA ratio may affect mtDNA replication [38] . In our study, we also examined the correlation between TFAM level and mtDNA and our data suggested that miR-214 level was also negatively correlated with mtDNA (data not shown), and miR-214 overexpression enhanced TFAM expression, which indicated a mechanism of TFAM involving in CRC.
Previous report demonstrated that down-regulation of TFAM in non-small cell lung cancer could activate reactive oxygen species (ROS)-mediated c-Jun N-terminal kinase(JNK)/ p38 mitogen-activated protein kinase (MAPK) signaling and reduce cellular bioenergetics which resulted in cell cycle arrest [16] . It was found in this study that TFAM expression could lead to the enhanced NF-κB activity as well as the promoted NF-κB dependent gene expression. In addition, the TFAM mRNA and protein levels were reported to be significantly elevated in a poorly differentiated rat hepatoma (Morris hepatoma) [39] . Increased TFAM expression levels were also observed in non-small cell lung cancer (NSCLC) and positively correlated to the malignancy and tumor grade as well [16] .
The situation of CRC patients with higher expression of TFAM was worse than patients with low TFAM expression in tumor tissues [40] , but the role TFAM played in CRC remains unclear. It was reported that TFAM depletion could result in upregulation of the levels of proapoptotic Bax, p21, tumor suppressor p53, and p-p53 (ser15), as well as poly ADP ribose polymerase (PARP), caspase 3 and caspase 9 cleavage [16] . In our study, TFAM knockdown by miR-214 mimic could reduce NF-κB nuclear translocation in vivo and in vitro. The assay conducted on cell lines also suggested that the reduced NF-κB nuclear translocation contributed to down-regulation of NF-κB depended genes. These data suggested a novel mechanism played by TFAM in CRC.
In conclusion, our study provided the clue that miR-214 expression was downregulated in CRC tissues and cell lines. Furthermore, miR-214 overexpression contributed to the enhanced TFAM expression and inhibited cell apoptosis. It was indicated that miR-214 and its target would be benefited for CRC treatment.
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